business
Novo Nordisk CFO On Metsera, Hims And Lilly, And Why 'Hyper Growth' Has Stalled - Investor's Business Daily
NOVO NORDISK REVERSES LOSSES AFTER CUTTING SALES OUTLOOK In a dramatic turn of events, Novo Nordisk's (NVO) stock price reversed its losses on Wednesday, closing with a fractional gain. The Danish drugmaker's shares had been facing downward pressure following the announcement that it would be cutting